Senescent cell transplantation into the skin induces age‐related peripheral dysfunction and cognitive decline
Ana Catarina Franco(Mayo Clinic), João F. Passos(Newcastle University), Diana Jurk(Mayo Clinic in Florida), Hélène Martini(Mayo Clinic), Cláudia Cavadas(University of Coimbra), Sundeep Khosla(WinnMed), Tamar Tchkonia(Cedars-Sinai Medical Center), Jennifer L. Rowsey(Mayo Clinic in Florida), Seung‐Hwa Woo(Daegu Gyeongbuk Institute of Science and Technology), Stella Victorelli(Mayo Clinic in Florida), Anthony B. Lagnado(Mayo Clinic), Nicholas Pirius(Mayo Clinic in Florida), Saranya P. Wyles(Mayo Clinic), Selim Chaib(Mayo Clinic), Daniela G. Costa(Mayo Clinic), Stefan G. Tullius(Brigham and Women's Hospital), James L. Kirkland(Cedars-Sinai Medical Center)
Cited by 26
Related Papers
The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
|Aging Cell|2015|2.4k
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
|EBioMedicine|2019|1.2k
Cellular senescence drives age-dependent hepatic steatosis
|Nature Communications|2017|1k
Cellular senescence and senolytics: the path to the clinic
|Nature Medicine|2022|1k